ATER
Aterian, Inc.
There isn't enough reported data to score ATER yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
ATER Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Under pressure | |
| Unavailable |
ATER's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ATER PE Valuation
ATER has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ATER Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| -- |
Analysts expect ATER's losses to shrink, with revenue growing.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ATER Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.98 | -$0.40 |
| Q1 2026 | -$2.56 | -$1.09 |
| Q4 2025 | -$2.39 | -$0.68 |
| Q3 2025 | -$1.61 | +$1.10 |
| Q2 2025 | -$1.58 | +$1.84 |
| Q1 2025 | -$1.47 | +$6.83 |
| Q4 2024 | -$1.71 | +$9.91 |
| Q3 2022 | -$36.44 | +$83.08 |
ATER is still losing money, but far less than before: $1.98 per share over the past year, against $119.52 at its worst in late 2021.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ATER Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7K | -100% |
| Q1 2026 | $18K | -100% |
| Q4 2025 | $15.1M | -39% |
| Q3 2025 | $19M | -28% |
| Q2 2025 | $19.5M | -30% |
| Q1 2025 | $15.4M | -24% |
| Q4 2024 | $24.6M | -25% |
| Q3 2024 | $26.2M | -34% |
ATER's revenue has slid since its 2021 peak: $7,000 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -56557% | -56534 points |
| Q1 2026 | -17828% | -17804 points |
| Q4 2025 | -51% | -45 points |
| Q3 2025 | -11% | -4.2 points |
| Q2 2025 | -23% | -12 points |
| Q1 2025 | -24% | +2.1 points |
| Q4 2024 | -6.5% | +19 points |
| Q3 2024 | -6.6% | +9.8 points |
ATER's operating margin was −56557% last quarter, down 56534 points from the same quarter a year ago, near the bottom of its range since 2019.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ATER on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID has the edge over ATER on profitability, with a higher operating margin.
ATER Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $424K | +$4.8M |
| Q1 2026 | -$367K | +$3.5M |
| Q4 2025 | -$1M | -$1M |
| Q3 2025 | -$1.6M | -$884K |
| Q2 2025 | -$4.4M | -253% |
| Q1 2025 | -$3.9M | -$3.8M |
| Q4 2024 | -$9K | +$5M |
| Q3 2024 | -$722K | -263% |
ATER has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ATER Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +316K shares |
| 1 year | +23% | +1.7M shares |
| 3 years | +43% | +2.8M shares |
| 5 years | +319% | +7M shares |
| Available history | +626% | +7.9M shares |
ATER has the edge over LCID on shareholder dilution, with a more favorable share count trend.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ATER Net Leverage
ATER's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ATER Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.7 | Neutral |
| Stochastic | 70.0 | Neutral |
ATER's weekly RSI is 55 (neutral) and its Stochastic is 70 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ATER PE vs Consumer Cyclical Sector
ATER has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ATER Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.70 | 24% above |
| 20 week MA | $0.70 | 24% above |
| 50 week MA | $0.77 | 13% above |
| 100 week MA | $1.17 | 26% below |
| 200 week MA | $3.20 | 73% below |
ATER has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ATER Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $73.8 | $200.3 | +171% |
| 2021 | $200.3 | $54.4 | -73% |
| 2022 | $54.4 | $9.54 | -82% |
| 2023 | $9.54 | $4.18 | -56% |
| 2024 | $4.18 | $2.37 | -43% |
| 2025 | $2.37 | $0.70 | -70% |
| 2026 YTD | $0.70 | $0.87 | +24% |
ATER has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.